Latest Breaking News On - Cholesterol drugs covid 19 - Page 1 : comparemela.com

A new international multi-institutional study led by scientists from Penn Medicine has found that fenofibrate was unable to reduce the severity of disease or prevent adverse outcomes such as deaths in COVID-19 patients.

United statesPexelx pavel danilyukWikimedia commonsJulio chirinosJordanab cohenNational institute for healthDrug administrationPenn medicineFighting fatRepresentational pictureNational instituteCare excellenceWestern asiaNorth americaCholesterol drugs covid 19Cholesterol drugs fails covid 19 human trials